IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, filed on October 30, 2018, by IRADIMED CORPORATION (a Delaware corporation and emerging growth company), serves to announce the Company's financial results for the third quarter ended September 30, 2018. The report references a press release furnished as Exhibit 99.1 containing the detailed results.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1) but are not explicitly stated in the body of this Form 8-K.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It solely indicates that third-quarter results have been issued.
Guidance, Outlook, and Risks
The filing does not include specific guidance, outlook, management commentary, risks, contingencies, or unusual items within the text provided. It notes that the information in Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated October 30, 2018) for actual revenue, net income, and cash flow figures.
- Verify year-over-year and quarter-over-quarter performance trends in the attached press release.
- Confirm the Company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Check for any forward-looking statements or risk factors detailed in the press release that are not present in this summary filing.